XML 101 R20.htm IDEA: XBRL DOCUMENT v2.4.1.9
Business Segments
 12 Months Ended
Dec. 31, 2014
Segment Reporting [Abstract]  
Business Segments
Business Segments
 
The Company has four reportable segments: Apex, Oxford, Physician, and Life Sciences Europe.

During the quarter ended March 31, 2014, the Company realigned its former Life Sciences Segment resulting in Lab Support U.S. now being included in the Apex Segment; Valesta U.S. now being included in the Oxford Segment; and the Life Sciences Europe Segment includes Lab Support Europe and Valesta Europe.

During 2014 the Company discontinued the operations of its European retained search unit, formerly included in the Life Sciences Europe Segment. During 2013, the Company sold its Nurse Travel and Allied Healthcare division (see "Note 5. Discontinued Operations" for further information). The realignment and divestitures resulted in changes to the internal reporting package reviewed by the Chief Operating Decision Maker ("CODM"), and the Healthcare Segment no longer exists. Health Information Management, formerly included in the Healthcare Segment, is included in the Oxford Segment and unallocated corporate expenses are separately disclosed in order to align with the revised internal reporting package reviewed by the CODM. All prior periods have been retrospectively restated to conform to the current presentation.

The Apex Segment provides information technology and scientific staffing professionals for contract, contract-to-hire and permanent placement positions to Fortune 1000 and mid-market clients across the United States, and offers consulting services for other select project-based needs. Apex Segment provides staffing and services support for companies from all major industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications.

The Oxford Segment provides high-end contract and direct hire placement services of information technology and engineering professionals with expertise in specialized information technology, software and hardware engineering, and mechanical, electrical, validation and telecommunications engineering fields.
    
The Physician Segment provides contract and direct hire placement physicians to healthcare organizations. The Physician Segment works with nearly all medical specialties, placing locum tenens physicians in hospitals, community-based practices, and federal, state and local facilities.

The Life Sciences Europe Segment provides services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical and environmental industries. These contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants and other skilled scientific professionals.

The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit, and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes. The Company's management does not evaluate, manage or measure performance of segments using asset information, and such information is not readily available. Accordingly, assets by reportable segment are not disclosed.

The following tables present revenues, gross profit, operating income and amortization by reportable segment (in thousands):

 
Year ended December 31, 2014
 
Apex
 
Oxford
 
Physician
 
Life Sciences Europe
 
Corporate
 
Total
Revenues
$
1,190,052

 
$
493,320

 
$
135,181

 
$
41,369

 
$
—

 
$
1,859,922

Gross Profit
335,322

 
208,607

 
40,477

 
13,506

 
—

 
597,912

Operating income
$
121,334

 
$
66,315

 
$
9,797

 
$
3,878

 
$
(55,054
)
 
$
146,270

Amortization
16,356

 
5,491

 
2,272

 
274

 
8

 
24,401


 
Year ended December 31, 2013
 
Apex
 
Oxford
 
Physician
 
Life Sciences Europe
 
Corporate
 
Total
Revenues
$
1,059,993

 
$
423,670

 
$
105,827

 
$
39,437

 
$
—

 
$
1,628,927

Gross Profit
294,611

 
147,348

 
30,614

 
12,916

 
—

 
485,489

Operating income
98,588

 
60,544

 
8,853

 
5,574

 
(49,179
)
 
124,380

Amortization
19,524

 
965

 
742

 
364

 
91

 
21,686

 
Year ended December 31, 2012
 
Apex

 
Oxford

 
Physician

 
Life Sciences Europe
 
Corporate
 
Total
Revenues
$
617,844

 
$
375,196

 
$
102,679

 
$
38,895

 
$
—

 
$
1,134,614

Gross Profit
174,968

 
132,034

 
31,455

 
14,252

 
—

 
352,709

Operating income
57,191

 
57,703

 
9,998

 
4,481

 
(47,101
)
 
82,272

Amortization
15,665

 
437

 
816

 
654

 
291

 
17,863

 
 
 
 
 
 
 
 
 
 
 
 
 
The Company operates internationally, with operations in the United States, Europe, Canada, Australia, and New Zealand. The following table represents revenues by geographic location (in thousands):
 
 
Year Ended December 31,
 
 
2014
 
2013
 
2012
Revenues:
 
 
 
 
 
 
Domestic
 
$
1,778,566

 
$
1,551,624

 
$
1,059,478

Foreign
 
81,356

 
77,303

 
75,136

 
 
$
1,859,922

 
$
1,628,927

 
$
1,134,614


 
The following table represents long-lived assets by geographic location (in thousands):
 
 
December 31,
 
 
2014
 
2013
 
2012
Long-lived Assets:
 
 
 
 
 
 
Domestic
 
$
52,936

 
$
44,598

 
$
40,062

Foreign
 
2,068

 
2,856

 
2,006

 
 
$
55,004

 
$
47,454

 
$
42,068